Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Liver Cancer treatment details. Biologic therapy. Queen Mary Hospital, Hong Kong, China



Survival: 4.3 months
   
Toxicity Grade: 3
   
Treatments: Biologic therapy
   
Drugs:
Country: China
   
City/State/Province: Hong Kong
   
Hospital: Queen Mary Hospital
   
Journal: Link
   
Date: 3/2012

Description:
Patients:
This phase II study involved 10 advanced hepatocellular carcinoma patients who had been previously treated with the biologic therapy agent sorafenib. The median patient age was 47 years and 70% were male.

Treatment:
Patients were treated with a combination of two biologic therapy agents, bevacizumab and erlotinib (a small molecular inhibitor of epidermal growth factor receptor tyrosine kinase, which is involved in cell growth and survival).

Toxicities:
The most severe treatment-related toxicities were of grade 3 and included rash, diarrhea, and vomiting.

Results:
The median overall survival was 4.37 months.

Correspondence: Dr. Thomas Yau; email: the@netvigator.com

E-mail to a Friend Email Physician More Information